1. Home
  2. ODC vs MLYS Comparison

ODC vs MLYS Comparison

Compare ODC & MLYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Oil-Dri Corporation Of America

ODC

Oil-Dri Corporation Of America

HOLD

Current Price

$48.73

Market Cap

790.1M

ML Signal

HOLD

Logo Mineralys Therapeutics Inc.

MLYS

Mineralys Therapeutics Inc.

HOLD

Current Price

$35.49

Market Cap

3.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ODC
MLYS
Founded
1941
2019
Country
United States
United States
Employees
N/A
N/A
Industry
Miscellaneous manufacturing industries
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
790.1M
3.1B
IPO Year
N/A
2023

Fundamental Metrics

Financial Performance
Metric
ODC
MLYS
Price
$48.73
$35.49
Analyst Decision
Strong Buy
Analyst Count
0
7
Target Price
N/A
$47.33
AVG Volume (30 Days)
88.0K
1.5M
Earning Date
12-08-2025
02-11-2026
Dividend Yield
1.68%
N/A
EPS Growth
17.33
N/A
EPS
3.63
N/A
Revenue
$478,113,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$13.44
N/A
Revenue Growth
5.29
N/A
52 Week Low
$40.66
$8.24
52 Week High
$69.76
$47.65

Technical Indicators

Market Signals
Indicator
ODC
MLYS
Relative Strength Index (RSI) 36.31 36.08
Support Level $45.61 $36.50
Resistance Level $54.16 $37.75
Average True Range (ATR) 1.70 1.65
MACD -0.06 0.01
Stochastic Oscillator 34.19 10.70

Price Performance

Historical Comparison
ODC
MLYS

About ODC Oil-Dri Corporation Of America

Oil-Dri Corp of America develops, manufactures, and markets sorbent products made predominantly from clay. Its absorbent offerings, which draw liquid up, include cat litter, floor products, toxin control substances for livestock, and agricultural chemical carriers. The company has two segments based on the different characteristics of two primary customer groups, namely the Retail and Wholesale Products Group, which derives maximum revenue, and the Business-to-Business Products Group. The company's products are sold under various brands such as Cat's Pride, Jonny Cat, Amlan, Agsorb, Verge, Pure-Flo, and Ultra-Clear.

About MLYS Mineralys Therapeutics Inc.

Mineralys Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing medicines to target diseases driven by abnormally elevated aldosterone. The company's product candidate, lorundrostat, is a proprietary, orally administered, selective aldosterone synthase inhibitor, that is initially developed for the treatment of patients with uncontrolled hypertension, defined as individuals who are unable to achieve BP of below 130/80 mmHg despite taking two or more lines of antihypertensive medication or resistant hypertension, typically including a diuretic.

Share on Social Networks: